- Proofpoint, Inc. stock price today and history
Proofpoint, Inc. (PFPT) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Proofpoint, Inc. stock price
Proofpoint, Inc. latest news:
Proofpoint agrees to buy Wombat Security Technologies for $225 million
Proofpoint Inc. said late Tuesday it had agreed buy Wombat Security Technologies Inc. for $225 million in cash. The deal is expected to close in the first quarter, the company said. The acquisition gives Proofpoint a foothold in the phishing simulation and security awareness training market. "The acquisition of Wombat gives us greater ability to help protect our customers from today's people-centric cyberattacks, as cybercriminals look for new ways to exploit the human factor," Proofpoint said in a statement. The company said it expects the deal to increase its 2018 revenue by $30 million to $32 million, and billings by $30 million to $32 million. Also Tuesday, Proofpoint reported an adjusted profit of 29 cents a share on sales of $145.4 million in the fourth quarter. That compares with adjusted earnings of 18 cents a share on sales of $106.8 million in the year-ago period. Analysts polled by FactSet had expected adjusted earnings of 20 cents a share on sales of $139.6 million. Proofpoint shares were flat in the extended session after ending the regular trading day up 3.6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
BRIEF-Proofpoint To Acquire Wombat Security Technologies For $225 Mln In Cash
Proofpoint Inc(PFPT): * PROOFPOINT ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE WOMBAT SECURITY TECHNOLOGIES FOR $225 MILLION IN CASH; MOVES INTO PHISHING SIMULATION AND SECURITY AWARENESS TRAINING MARKET. * Proofpoint Inc(PFPT) - EXPECTS WOMBAT TO INCREASE 2018 REVENUE RANGE BY $30 MILLION - $32 MILLION. * Proofpoint Inc (PFPT) - EXPECTS WOMBAT TO INCREASE 2018 BILLINGS RANGE BY $30 MILLION - $32 MILLION.
ProPhase Labs, Inc.PRPH
ProQR Therapeutics N.V.PRQR
ProShares Ultra search BiotechnologyBIB
Proshares UltraPro search BiotechnologyUBIO
ProShares UltraPro QQQTQQQ
ProShares UltraPro Short search BiotechnologyZBIO
ProShares UltraPro Short QQQSQQQ
ProShares UltraShort search BiotechnologyBIS
Prospect Capital CorporationPSEC
Proteon Therapeutics, Inc.PRTO